These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29414878)

  • 1. Histone Deacetylase Inhibitor Induced Radiation Sensitization Effects on Human Cancer Cells after Photon and Hadron Radiation Exposure.
    Gerelchuluun A; Maeda J; Manabe E; Brents CA; Sakae T; Fujimori A; Chen DJ; Tsuboi K; Kato TA
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays.
    Barazzuol L; Jeynes JC; Merchant MJ; Wéra AC; Barry MA; Kirkby KJ; Suzuki M
    Int J Radiat Biol; 2015 Jan; 91(1):90-8. PubMed ID: 25040548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoylanilide hydroxamic acid as a radiosensitizer through modulation of RAD51 protein and inhibition of homology-directed repair in multiple myeloma.
    Chen X; Wong P; Radany EH; Stark JM; Laulier C; Wong JY
    Mol Cancer Res; 2012 Aug; 10(8):1052-64. PubMed ID: 22729783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of radiation response by histone deacetylase inhibition.
    Chinnaiyan P; Vallabhaneni G; Armstrong E; Huang SM; Harari PM
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):223-9. PubMed ID: 15850925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
    Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.
    Lee JH; Choy ML; Ngo L; Foster SS; Marks PA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14639-44. PubMed ID: 20679231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity.
    Konsoula Z; Cao H; Velena A; Jung M
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1541-8. PubMed ID: 21277099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy.
    Johnson AM; Bennett PV; Sanidad KZ; Hoang A; Jardine JH; Keszenman DJ; Wilson PF
    Front Oncol; 2021; 11():735940. PubMed ID: 34513712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by the histone deacetylase inhibitor PCI-24781.
    Banuelos CA; Banáth JP; MacPhail SH; Zhao J; Reitsema T; Olive PL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6816-26. PubMed ID: 18006784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
    Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L
    Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation.
    Fujisawa H; Nakajima NI; Sunada S; Lee Y; Hirakawa H; Yajima H; Fujimori A; Uesaka M; Okayasu R
    Radiat Oncol; 2015 Aug; 10():175. PubMed ID: 26286029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells.
    Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
    Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE
    Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP.
    Chao OS; Goodman OB
    Mol Cancer Res; 2014 Dec; 12(12):1755-66. PubMed ID: 25127709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase Inhibitors Sensitize Murine B16F10 Melanoma Cells to Carbon Ion Irradiation by Inducing G1 Phase Arrest.
    Saito K; Funayama T; Yokota Y; Murakami T; Kobayashi Y
    Biol Pharm Bull; 2017; 40(6):844-851. PubMed ID: 28566628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in histone acetylation following exposure to
    Tian XL; Lu X; Feng JB; Cai TJ; Li S; Tian M; Liu QJ
    Radiat Environ Biophys; 2018 Aug; 57(3):215-222. PubMed ID: 29774413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines.
    Feng X; Han H; Zou D; Zhou J; Zhou W
    Oncotarget; 2017 Jan; 8(2):3364-3379. PubMed ID: 27926517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxyamic acid modification of chromatin architecture affects DNA break formation and repair.
    Singh S; Le H; Shih SJ; Ho B; Vaughan AT
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):566-73. PubMed ID: 20117292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.